. 2018 Nov 6;13:184. doi: 10.1186/s13023-018-0927-y

Table 4.

Total Public Expenditure on OMPs in 2013 and 2014 compared to GDP, Total Pharmaceutical and Healthcare Budget

	Austria^c	Belgium	Bulgaria	Czech Republic	Hungary	Poland	Slovenia
2013
Total public expenditures on OMPs (thousand €)	98,600^a	245,000^a	8266^a	42,340^a	32,262^a	50,649^a	16,893^a
Total GDP (thousand €)	322,539,200^b	391,712,000^b	42,011,500^b	157,741,600^b	101,483,300^b	394,721,100^b	35,917,100^b
Total public expenditures on OMPs in proportion of GDP (%)	0.03%	0.06%	0.02%	0.03%	0.03%	0.01%	0.05%
% of total pharmaceutical expenditures	3.74% ^e	6.18% ^f	3.07% ^g	2.00% ^h	3.42% ⁱ	1.95% ^j	4.65% ^k
% of total healthcare expenditures	NA	0.91% ^f	NA	0.4% ^h	0.53% ⁱ	0.34% ^j	0.74% ^k
Total pharmaceutical expenditures (thousand €) (calculated)	2,636,364	3,964,401	269,248	2,117,013	943,332	2,597,381	363,297
Total healthcare expenditures (thousand €) (calculated)	NA	26,923,077	NA	10,585,065	6,087,161	14,896,746	2,282,879
2014
Total public expenditures on OMPs (thousand €) (Growth compared to 2013, %)	109,800 (+ 11.4%)^a	280,000 (+ 14.3%)^a	12,228 (+ 47.9%)^a	50,835 (+ 20.1%)^a	40,498 (+ 25.5%)^a	83,341 (+ 64.5%)^a	19,854 (+ 17.5%)^a
Total GDP (thousand €)	330,417,600^b	400,805,000^b	42,762,200^b	166,964,100^b	104,953,300^b	410,989,700^b	37,332,400^b
Total public expenditures on OMPs in proportion of GDP (%)	0.03%	0.07%	0.03%	0.03%	0.04%	0.02%	0.05%
% of total pharmaceutical expenditures	3.94%^e	6.84% ^f	4.15% ^g	2.50% ^h	4.25% ⁱ	3.2% ^j	5.47% ^k
% of total healthcare expenditures	NA	1.01% ^f	NA	0.60% ^h	0.66% ⁱ	0.54% ^j	0.84% ^k
Total pharmaceutical expenditures (thousand €) (calculated)	2,786,802	4,093,567	294,654	2,033,406	952,883	2,604,432	362,956
Total healthcare expenditures (thousand €) (calculated)	NA	27,722,772	NA	8,472,525	6,135,990	15,433,670	2,363,538
Total public expenditures on OMPs in proportion of GDP (%) in 2013	0.03%	0.06%	0.02%	0.03%	0.03%	0.01%	0.05%
Total public expenditures on OMPs in proportion of GDP (%) in 2014	0.03%	0.07%	0.03%	0.03%	0.04%	0.02%	0.05%
Average	0.03%	0.07%	0.02%	0.03%	0.04%	0.02%	0.05%
Total public expenditure on OMPs as a proportion of total public pharmaceutical expenditures in 2013	3.74%	6.18%	3.07%	2.00%	3.42%	1.95%	4.65%
Total public expenditure on OMPs as a proportion of total public pharmaceutical expenditures in 2014	3.94%	6.84%	4.15%	2.50%^d	4.25%	3.20%	5.47%
Average	3.84%	6.51%	3.61%	2.25%	3.84%	2.58%	5.06%
Total public expenditure on OMPs as a proportion of total public healthcare expenditures in 2013	NA	0.91%	NA	0.40%	0.53%	0.34%	0.74%
Total public expenditure on OMPs as a proportion of total public healthcare expenditures in 2014	NA	1.01%	NA	0.60%^d	0.66%	0.54%	0.84%
Average	NA	0.96%	NA	0.50%	0.60%	0.44%	0.79%

Sources: ^a Data was given from Table 1

^bhttp://ec.europa.eu/eurostat/tgm/refreshTableAction.do?tab=table&plugin=1&pcode=tec00001&language=en

^cOrphan drug expenditure in hospitals not included

^dData was not available at time of data request. this number assumes same total expenditure on public healthcare as in year 2013

^eFederation of Austrian Social Insurance Institutions (Hauptverband der österreichischen Sozialversicherungsträger)

^fNational Institute for Health and Disability Insurance of Belgium (Institut National d'Assurance Maladie-Invalidité / Rijksinstituut voor ziekte-en invaliditeitsverzekering, INAMI / RIZIV)

^gNational Health Insurance Fund of Bulgaria, National Council on Prices and Reimbursement of Medicinal Products

^hState Institute for Drug Control (Státní ústav pro kontrolu léčiv, SUKL)

ⁱNational Health Insurance Fund Administration of Hungary (Országos Egészségbiztosítási Pénztár, OEP)

^jNational Health Fund (Narodowy Fundusz Zdrowia), Ministry of Health (Ministerstwo Zdrowia)

^kHealth Insurance Institute of Slovenia (Zavod za zdravstveno zavarovanje Slovenije, ZZZS)